InvestorsHub Logo
Followers 21
Posts 2935
Boards Moderated 0
Alias Born 01/27/2022

Re: BioInvestor3 post# 383106

Wednesday, 07/13/2022 11:32:56 AM

Wednesday, July 13, 2022 11:32:56 AM

Post# of 429367
True, but I think at this point, they are betting that getting the approvals and reimbursements in place, and getting scripts flowing (unencumbered by profit split), puts them in a better position for a sale to a BP.

If they partner with selling agents in EU now (ie. HLS/Pfizer), there is very little "profit" left to sell, unless they sell to whoever the selling agent is (for example if PFE or AZ sold for them in EU).

Basically, I think KM was pretty much backed into a a corner in terms of the current strategy.

I don't think partnering was ever a good idea in EU or USA. Selling the company to a BP was the move. But since Thero screwed the pooch on that, we really need to see the GIA strategy through to a sale.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News